Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Melissa Pickett: HIT Detection Can Miss a Critical Platelet Decline
Nov 20, 2026, 14:17

Melissa Pickett: HIT Detection Can Miss a Critical Platelet Decline

Melissa Pickett, Legal Nurse Consultant at Peaceful Views, LLC, shared a post on LinkedIn:

“A platelet count can fall by half and still read ‘normal.’

If a heparin file with a clot leaves you staring at pages of lab values, unsure which ones matter, you are not missing something. Lab reports are written for clinicians, one day at a time.

On October 30, the FDA posted its most serious type of recall for four lots of a test used to detect heparin-induced thrombocytopenia or HIT, a reaction to heparin that can cause dangerous clots.

The affected lots can read 20 to 35 percent low, enough that a positive sample may be reported as negative. No serious injuries had been reported as of September 3.

On the cardiac step-down unit, many of my patients were on heparin drips. Each morning I compared the platelet count to that patient’s own starting number, not just the normal range.

One step for your next heparin file: build a one-line platelet timeline. Start with the count on the day heparin began, add every count after it by date, and mark any HIT test and what happened to the heparin next. A fall from 320,000 to 160,000 is a 50 percent drop, and most lab reports still call it normal.

I do not diagnose HIT. I flag the pattern, explain it plainly, and connect you with the right hematology expert.

Where in your files could the patient’s own baseline change the story?”

Melissa Pickett: HIT Detection Can Miss a Critical Platelet Decline

Stay updated with Hemostasis Today.